Drug
ZN-d5
ZN-d5 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 75.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_1
4
100%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 1
Trials by Phase
Phase 14 (100.0%)
Trials by Status
terminated125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_1
Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis
NCT05199337
completedphase_1
A Food Effect Study of ZN-d5 in Healthy Female Volunteers
NCT04854174
completedphase_1
Phase 1 First in Human Study of ZN-d5 as a Single Agent
NCT04500587
terminatedphase_1
A Phase I Study of ZN-d5 in Chinese Subjects With Non-Hodgkin Lymphoma
NCT05127811
Clinical Trials (4)
Showing 4 of 4 trials
NCT05199337Phase 1
Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis
NCT04854174Phase 1
A Food Effect Study of ZN-d5 in Healthy Female Volunteers
NCT04500587Phase 1
Phase 1 First in Human Study of ZN-d5 as a Single Agent
NCT05127811Phase 1
A Phase I Study of ZN-d5 in Chinese Subjects With Non-Hodgkin Lymphoma
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4